Affiliations 

  • 1 Faculty of Chemical Engineering, Universiti Teknologi Malaysia (UTM), 81310 Skudai, Johor, Malaysia
  • 2 Department of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, Iran
  • 3 Department of Chemical Engineering, Amirkabir University of Technology (Tehran Polytechnic), Hafez Ave., P.O. Box 15875-4413, Tehran, Iran; Medical Biomaterials Research Center (MBRC), Tehran University of Medical Science, Tehran, Iran. Electronic address: irani_mo@ut.ac.ir
  • 4 Medical Biomaterials Research Center (MBRC), Tehran University of Medical Science, Tehran, Iran
Mater Sci Eng C Mater Biol Appl, 2015 Mar;48:384-90.
PMID: 25579938 DOI: 10.1016/j.msec.2014.12.039

Abstract

Polyethylene oxide (PEO)/chitosan (CS)/graphene oxide (GO) electrospun nanofibrous scaffolds were successfully developed via electrospinning process for controlled release of doxorubicin (DOX). The SEM analysis of nanofibrous scaffolds with different contents of GO (0.1, 0.2, 0.5 and 0.7wt.%) indicated that the minimum diameter of nanofibers was found to be 85nm for PEO/CS/GO 0.5% nanofibers. The π-π stacking interaction between DOX and GO with fine pores of nanofibrous scaffolds exhibited higher drug loading (98%) and controlled release of the DOX loaded PEO/CS/GO nanofibers. The results of DOX release from nanofibrous scaffolds at pH5.3 and 7.4 indicated strong pH dependence. The hydrogen bonding interaction between GO and DOX could be unstable under acidic conditions which resulted in faster drug release rate in pH5.3. The cell viability results indicated that DOX loaded PEO/CS/GO/DOX nanofibrous scaffold could be used as an alternative source of DOX compared with free DOX to avoid the side effects of free DOX. Thus, the prepared nanofibrous scaffold offers as a novel formulation for treatment of lung cancer.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.